Wall Street Journal - 07-13-2026 - New FDA-cleared blood tests are helping neurologists diagnose early signs of Alzheimer's, and more - Read by Merrick Schneider - AIRSLA

Show Notes for Wall Street-AIRSLA Merrick Schneider introduces a podcast episode from July 13, 2026, featuring a selection of articles from the Wall Street Journal; New FDA-cleared blood tests are helping neurologists diagnose early signs of Alzheimer's, though they are not intended for healthy individuals and require professional confirmation; Major brewers are expanding their product lines with smaller 7 to 9-ounce cans, known as "ponies," which appeal to consumers looking to moderate their alcohol intake; The California Coastal Commission is involved in a contentious legal battle with a homeowner in Carlsbad over allegations of blocking public access to the beach and a lagoon; Gilead Sciences and AstraZeneca have received FDA approval for new antibody-drug conjugates that offer promising treatments for triple-negative breast cancer; The medical profession's terminology, such as "geriatric pregnancy" and "incompetent cervix," is criticized for being insensitive and poorly marketed; A reflection on turning 70 highlights the changes in social gatherings, priorities, and health awareness as the class of '56 navigates this milestone. AIRSLA This podcast is produced by Audio Internet Reading Service of Los Angeles (AIRSLA). These recordings are provided solely for the use of the blind and print impaired. Materials or items read on AIRSLA are the copyright property of the original authors and publishers. No unauthorized use or duplication is permitted. Contact Information\ website: https://airsla.org\ email: [email protected]\ \